The 8th Cell Therapy Analytical Development Summit focuses on advancing analytical methods, technologies, and regulatory strategies to improve the development, quality, and efficiency of cell therapies.
Key Topics
Analytical & Regulatory Frontiers to Propel Cell Therapy Development Forward
Overcoming Complexities in Assessing Therapeutic Efficacy
Complexities in Assay Qualification for Immunophenotyping for Enhanced Consistency & Repeatability
Expedited Release of Cell Therapy Products with Accelerated Testing Timelines
Automation & Technology to Streamline Processes & Speed Up Assay Development
Overcoming the Challenges of Immunophenotype Assays with Robust Data Strategy
Transitioning from Conventional Approaches to Enhance Cost Effectiveness & Efficiency
Analytical Lifecycle for Strategic Management & Streamlined Product Development
Overcoming Ongoing Analytical Development Hurdles in Cell Therapy to Accelerate Therapeutic Advancements
Standardized Protocols for Characterization Across the Cell Therapy Modalities
Optimizing Sample Management & Handling for Enhanced Immunophenotype Assays
Strategies to Address Variability in Cell-Based Assays for Enhanced Reliability
Immunophenotype Assays with Technologies & Methodologies for Cell Therapy Excellence
Strategies for Efficient Cell Therapy Production & Regulatory Compliance
